Articles

Company boosts outlook but may slightly miss Wall Street's earnings mark.

Retail investors are falling back into a bad habit of following a herd.

Oil futures start the week with a tumble as Saudi price cuts underline fears about demand.

Merck announced Monday an agreement to buy cancer treatment developer Harpoon Therapeutics in a deal valued at $680 million.

Goldman Sachs believes U.K. stocks will break a period of underperformance and is targeting a gain of about 7% for British blue-chips this year.

The plunge in Boeing's stock isn't the only reason the Dow Jones Industrial Average is headed lower, but it's the reason the index is set to underperform other broad-market barometers.

Innovative chip makers, power management companies and database providers will enable AI's growth whether the stock market is up or down.

Morgan Stanley strategist outlines three playbooks for what could hit the U.S. economy.

Gains for far-right, anti-immigrant candidates could foreshadow November's U.S. election results.

A helpful aunt wants to know the best way to save for college for her relatives.

Post Content

"My father recently passed away at 75, without a will. At the time, he was divorced from his fifth wife and had a fiancée."